The Multidisciplinary Association for Psychedelic Studies (MAPS) Canada is committed to planning, conducting and publishing scientific research and education supporting the beneficial uses of psychedelic medicines, including treatment for medical conditions, neuroscience, creativity and spirituality.
Supported by rigorous scientific evaluation of risks and benefits and through partnerships with academic, health, hospital and community organizations, MAPS Canada envisions a world where psychedelic therapies are legally and widely available.
The series will consist of 14 episodes, each containing a presentation by someone in the rapidly advancing field of psychedelics. Our goal with the webinar series would be to bring forward important voices in the psychedelic sphere to discuss all sorts of topics related to psychedelics and the path to legalization. We’ll have content on the sacred language of plant medicines, MDMA-Assisted Psychotherapy, visionary art and everything in between!
Current research with psychedelics is yielding promising results in the treatment of trauma, end of life anxiety, depression and addiction. This wave of resurgence has not come about by chance. At the heart of this psychedelic renaissance is a solid foundation of rigorous scientific studies on these substances and MAPS Canada is the organization that has been spearheading a lot of this important work in Canada.
Currently, MAPS Canada has been supporting studies to legalize MDMA-assisted psychotherapy for the treatment of post-traumatic stress disorders which are now entering into the final phases of clinical trials.
Hear more from Mark Haden, Executive Director of MAPS Canada about the exciting and transformative future of psychedelic treatments in the video above.
We have currently raised $209,000 towards our new stretch goal of 250k
Our guest for the first episode of the webinar series will be Mark Haden, Executive Director for MAPS Canada. Mark will be discussing MAPS Canada’s
Examining the Psychedelic Renaissance We are in the middle of the psychedelic renaissance. With research projects and decriminalization proposals popping up across North America and
While psychedelics are in the midst of their second pass at mainstream legitimacy, the public perception of psychedelic advocates hasn’t changed much since the 1960s.
Almost anyone taking psychedelics, whether rookie or veteran, reports feelings of enhanced creativity. Defining creativity is a slippery slope and these reports are especially subjective,
Even under brief examination it is clear that in the demographics of the modern psychedelic medicine movement, there is a significant underrepresentation of people of
In order to understand why psychedelics are considered such a promising potential treatment for depression, it is vital to understand a little bit about how the brain works.
